Clearance Summary
ACCESS EPO ASSAY received FDA 510(k) clearance under submission number K052223, sponsored by Beckman Coulter, Inc.. The device was reviewed via the Abbreviated premarket notification pathway and assigned to the Hematology review panel. The statutory decision date of record is 2006-10-06.
- Submission: K052223
- Applicant / Sponsor: Beckman Coulter, Inc.
- Clearance pathway: Abbreviated
- Review panel: Hematology
- Device class: Class II
- Regulation citation: 21 CFR 864.7250
- Decision date: 2006-10-06
Classification & Regulation
This clearance is catalogued under FDA product code GGT and 21 CFR 864.7250, within the Hematology review panel as a Class II device.